Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Organisation › Details

Dropprint Genomics (US)

March 2021 Immunai, a New York and Tel Aviv-based biotech company, announced its acquisition of Dropprint Genomics, a San Francisco-based single-cell genomics software company. Immunai is also expanding its executive leadership team and scientific advisory board with experts in immunology, single-cell technologies and machine learning. Both the acquisition and new hires will advance the company’s work in single cell functional genomics with the goal of better supporting discovery, prioritization, and development of new therapies and drug combinations. Dropprint Genomics, a Y Combinator-backed startup, has developed computational infrastructure to conduct single-cell sequencing at scale, developed proprietary methods for cost-effective processing of hundreds of patient samples, and built a large database of immune cells from autoimmune and cancer cohorts. These cells will be incorporated into Immunai’s Annotated Multi-omic Immune Cell Atlas (AMICA™), which is already the world’s largest single cell database. Immunai welcomes the Dropprint team, including co-founders Meena Subramaniam, PhD, and Rachel Gate, PhD, who have joined the Machine Learning and Computational Biology team at Immunai. This team brings deep experience in genomics and bioinformatics from the University of California, San Francisco. *


Period Start 2021-03-25 splitoff before
Period End 2021-03-25 acquired
  Group Immunai (Group)
  Predecessor University of California, San Francisco (UCSF)
Products Industry genomic software tools
  Industry 2 single cell analysis
Person Person Gate, Rachel (Dropprint Genomics 202103 CEO + Co-Founder)
Region Region San Francisco, CA
  Country United States (USA)
  City n. a. San Francisco, CA
    Address record changed: 2021-04-06
Basic data Employees n. a.
    * Document for �About Section�: Immunai. (3/25/21). "Press Release: Immunai Acquires Dropprint Genomics and Strengthens Leadership Team with Experts in Immunology to Expand Target Discovery Capabilities". New York, NY.
Record changed: 2021-04-06


Picture [iito] Plain Stupid Simple 650x80px

More documents for Immunai (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top